Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MP Biomedicals™ Bradykinin

Catalog No. ICN10111201 Shop All MP Biomedicals, Inc Products
Change view
Click to view available options
Quantity:
1 mg
5 mg
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
ICN10111201 1 mg
ICN10111205 5 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Catalog No. ICN10111201 Supplier MP Biomedicals™ Supplier No. 0210111201

Pro-inflammatory peptide acting through G-protein-coupled receptors

Bradykinin activates sphingolipid metabolism. Fibroblasts treated with bradykinin produce a rapid and important increase in ceramide which is followed by a transient rise in sphingosine content. The peptide also increases ceramide cellular content by rapidly mobilizing neutral glycolipids. Bradykinin plays an important role in the regulation of fluid and electrolyte balance, smooth muscle contraction, vasodilation and capillary permeability. The bradykinin potentiators, which possess no bradykinin activity themselves, enhance the activity of bradykinin.

  • Synonyms: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg
  • CAS Number: 5979-11-3
  • EC Number: 227-781-2
  • Physical Appearance: White powder
  • Format: Supplied as acetate salt
  • Soluble in 0.1M HOAc (25mg/mL)

TRUSTED_SUSTAINABILITY

Specifications

Purity >99%
Content And Storage -20°C
Format Powder
Molecular Weight (g/mol) 1060.22
Product Type Bradykinin
Quantity 1 mg
Sequence H2N-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.